Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Adapalene wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Mostly mechanism / observational
Top outcomes
Topical use. Adapalene 0.1% (OTC) or 0.3% (prescription) gel/cream is applied as a thin layer to the whole affected area once daily, usually at night, starting every other day and building to nightly as tolerated. Full benefit takes ~8-12 weeks. There is no oral or systemic dose — it is not ingested. It is most effective combined with benzoyl peroxide. This library does not provide an ingestion protocol.
evening
Adapalene 0.1% gel/cream (OTC), applied nightly to the whole area
Topical cosmetic. Cysteamine 5% cream is typically applied once daily to areas of melasma as a short-contact treatment (left on for ~15 minutes, then washed off) to limit odor and irritation, with daily sunscreen. There is no oral or systemic use in this context. This library does not provide an ingestion protocol.
any
Cysteamine 5% cream (short-contact application)
Throughout
8-12 weeks
Throughout
First weeks
Throughout
8-16 weeks
Throughout
Throughout
A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: a meta-analysis of five randomized trials.
Br J Dermatol (1998) · Meta analysis · n=900
Meta-analysis of five randomized investigator-blind trials (900 patients) in mild-to-moderate acne
Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study.
J Am Acad Dermatol (2007) · Rct · n=517
Pivotal 12-week double-blind RCT (n=517) of adapalene-BPO vs adapalene, BPO, or vehicle
Topical preparations for the treatment of mild-to-moderate acne vulgaris: systematic review and network meta-analysis.
Br J Dermatol (2021) · Systematic review
Systematic review and network meta-analysis of 40 trials (18,089 participants) of topical acne treatments
Evaluation of the efficacy of cysteamine 5% cream in the treatment of epidermal melasma: a randomized double-blind placebo-controlled trial.
Br J Dermatol (2015) · Rct · n=50
First double-blind placebo-controlled RCT of cysteamine 5% cream for epidermal melasma (n=50), nightly for 4 months
Efficacy of cysteamine cream in the treatment of epidermal melasma, evaluating by Dermacatch as a new measurement method: a randomized double blind placebo controlled study.
J Dermatolog Treat (2018) · Rct · n=40
Second double-blind placebo-controlled RCT (n=40), nightly cysteamine 5% for 4 months, with Dermacatch and Mexameter colorimetry
A comparative study of topical 5% cysteamine versus 4% hydroquinone in the treatment of facial melasma in women.
Int J Dermatol (2020) · Rct · n=40
Multicenter evaluator-blinded head-to-head of cysteamine 5% vs hydroquinone 4% (n=40), nightly for 120 days with sunscreen
Adapalene has a higher evidence score (9/10 vs 6/10) and wins in 2 of 3 categories.
No known interactions between Adapalene and Cysteamine (topical) have been documented in our database. However, always consult a healthcare provider before combining supplements.